Presentation Information
[[E]F402-3pm-02]Research and Development of CLK inhibitor CTX-712
Challenge of spinout biotech company
○Hiroshi Miyake1 (1. Chordia Therapeutics Inc.)
Keywords:
biotech,spinout,small molecule drug,oncology